LPA1 receptor antagonist 1
CAS No. 1396006-71-5
LPA1 receptor antagonist 1 ( —— )
产品货号. M33412 CAS No. 1396006-71-5
LPA1 receptor antagonist 1 是具有高度选择性的,溶血磷脂酸 (LPA1) 受体的一个拮抗剂,其 IC50 值为 25 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1872 | 有现货 |
|
| 10MG | ¥2689 | 有现货 |
|
| 25MG | ¥4046 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称LPA1 receptor antagonist 1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LPA1 receptor antagonist 1 是具有高度选择性的,溶血磷脂酸 (LPA1) 受体的一个拮抗剂,其 IC50 值为 25 nM。
-
产品描述LPA1 receptor antagonist 1 is a highly selective Lysophosphatidic Acid receptor-1 (LPA1) antagonist with an IC50 of 25 nM.
-
体外实验LPA1 receptor antagonist 1 (compound 2) displays very potent and highly selective inhibitory activity toward LPA1, with little inhibition on LPA3 even at very high concentrations. To our knowledge, LPA1 receptor antagonist 1 is the most selective nonlipid LPA1 antagonist so far reported. It appears that compounds (e.g., LPA1 receptor antagonist 1) from the N-aryltriazole chemical class are much more selective for LPA1 than compounds from the corresponding pyrazole series. In comparison with Ki16425 and AM095, LPA1 receptor antagonist 1 shows much improved antiproliferative activity. LPA1 receptor antagonist 1 demonstrates the highest LPA1 selectivity and attenuated LPA-induced NHLF proliferation and contraction with high potency.
-
体内实验Oral dosing of LPA1 receptor antagonist 1 in mice causes a dose-dependent reduction in serum histamine levels induced following intravenous LPA stimulation. When mice are orally dosed with LPA1 antagonist 1 (100 mg/kg, aqueous suspension) prior to intravenous LPA injection, the LPA-induced histamine level is significantly blocked A clear PK/PD relationship is demonstrated by the correlation between the levels of LPA1 receptor antagonist 1 and LPA-induced histamine concentrations in plasma. Although AM095 almost completely blocks histamine release (100 mg/kg), analysis of plasma samples revealed more than 65-fold higher concentrations of AM095 than LPA1 receptor antagonist 1 (100 mg/kg). The ability of LPA1 receptor antagonist 1 to block histamine release at much lower plasma concentration suggests that further improvement of pharmacokinetic properties of this chemical class could lower the effective dose.
-
同义词——
-
通路GPCR/G Protein
-
靶点LPA Receptor
-
受体LPA Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number1396006-71-5
-
分子量482.53
-
分子式C28H26N4O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(O)(=O)C1(CC1)C2=CC=C(C=C2)C3=CC=C(C=C3)N4C(NC(O[C@H](C)C5=CC=CC=C5)=O)=C(C)N=N4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Qian Y, et al. Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts. J Med Chem. 2012 Sep 13;55(17):7920-39.?
产品手册
关联产品
-
TAK-615
TAK-615 通常用于研究肺纤维化,是 LPA1 受体的负变构调节剂。
-
DBIBB
DBIBB 是溶血磷脂酸 (LPA2) 的 2 型 G 蛋白偶联受体的特异性非脂质激动剂。DBIBB 可减轻胃肠道辐射综合征,增加肠隐窝存活率和肠细胞增殖,并减少细胞凋亡 (apoptosis)。DBIBB 是一种能够缓解高剂量 γ 射线对造血和胃肠系统引起的急性放射综合征的候选活性分子。
-
Radioprotectin-1
Radioprotectin-1 是 LPA2 的选择性激动剂,对鼠 LPA2 GPCR 的 EC50 为 25 nM,并发挥辐射防护和辐射缓解作用。
021-51111890
购物车()
sales@molnova.cn

